CLINICAL_TRIALS
withdrawal
· 2019-02-04
Clinical Trial Update: Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study
Summary
A post-market study evaluating Abbott's Brio deep brain stimulation system for Parkinson's disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Parkinson Disease | Status: WITHDRAWN